Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	188-189
Journal	Lancet diabetes & endocrinology
Volume	4
Issue number	3
DOIs	https://doi.org/10.1016/S2213-8587(15)00457-X
Publication status	Published - Mar 2016

Access to Document

@article{47cd763209d248108b585a7a00a2c4d8,

title = "Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes",

author = "Muskiet, {Marcel H. A.} and {van Bommel}, {Erik J. M.} and {van Raalte}, {Daniel H.}",

year = "2016",

month = mar,

doi = "10.1016/S2213-8587(15)00457-X",

language = "English",

volume = "4",

pages = "188--189",

journal = "Lancet diabetes & endocrinology",

issn = "2213-8587",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes

AU - Muskiet, Marcel H. A.

AU - van Bommel, Erik J. M.

AU - van Raalte, Daniel H.

PY - 2016/3

Y1 - 2016/3

U2 - 10.1016/S2213-8587(15)00457-X

DO - 10.1016/S2213-8587(15)00457-X

M3 - Comment/Letter to the editor

VL - 4

SP - 188

EP - 189

JO - Lancet diabetes & endocrinology

JF - Lancet diabetes & endocrinology

SN - 2213-8587

IS - 3

ER -